22.79 USD
▲-0.13+4.49%
盘后 21.81 0.00%
2026-08-03
市值
$1.63B
市盈率
—
EPS
-1.36
股息率
—
52 周区间
11.51 – 29.75
成交量
355.68K
Beta
1.13
目标价
39.33
52W 低 11.5152W 高 29.75
价格走势
公司简介
Zymeworks Inc., a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases. The company’s platforms include Azymetric multispecific antibody platform; Drug Conjugate platform that includes a suite of proprietary cytotoxins comprising topoisomerase and microtubulin inhibiting toxins, stable linkers, and conjugation technologies; EFECT platform, which consists of a set of modifications to the Fc region of antibodies; and ProTECT, a tumor-specific immune co-stimulation platform. Its lead pr...